30 December 2025
Cancers | Title Story Articles from the Second Half of 2025
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to present a list of title story articles selected to feature at the top of the Cancers (ISSN: 2072-6694) homepage for the second half of 2025. These articles cover a wide range of topics, including cancer genomics, whole-genome sequencing, cancer diagnosis and therapy, cancer metastasis, liquid biopsy, precision oncology and quality of life. We hope you find these publications to be of particular interest.
1. “The Concept of “Platinum Sensitivity” in Endometrial Cancer”
by Shoji Nagao, Atsushi Fujikawa, Ryoko Imatani, Yoshinori Tani, Hirofumi Matsuoka, Naoyuki Ida, Junko Haraga, Chikako Ogawa, Keiichiro Nakamura and Hisashi Masuyama
Cancers 2025, 17(15), 2557; https://doi.org/10.3390/cancers17152557

2. “L1CAM Reliably Distinguishes Low-Grade Oncocytic Tumor from Other Eosinophilic Renal Neoplasms: A Multicenter Immunohistochemical Study with Diagnostic Implications”
by Luciana Scuccimarri, Antonio d’Amati, Francesco Pierconti, Angela Santoro, Luigia Ciampi, Tiziana Montrone, Francesco Alfredo Zito, Giuseppe Lucarelli, Guido Rindi, Gian Franco Zannoni et al.
Cancers 2025, 17(15), 2440; https://doi.org/10.3390/cancers17152440

3. “Scaling for African Inclusion in High-Throughput Whole Cancer Genome Bioinformatic Workflows”
by Jue Jiang, Georgina Samaha, Cali E. Willet, Tracy Chew, Vanessa M. Hayes and Weerachai Jaratlerdsiri
Cancers 2025, 17(15), 2481; https://doi.org/10.3390/cancers17152481

4. “Comprehensive Longitudinal Linear Mixed Modeling of CTCs Illuminates the Role of Trop2, EpCAM, and CD45 in CTC Clustering and Metastasis”
by Seth D. Merkley, Huining Kang, Ursa Brown-Glaberman and Dario Marchetti
Cancers 2025, 17(16), 2717; https://doi.org/10.3390/cancers17162717

5. “Integrating Molecular Phenotyping into Treatment Algorithms for Advanced Oestrogen Receptor-Positive Breast Cancer”
by Sarah Childs, Ryoko Semba, Lucy Haggstrom and Elgene Lim
Cancers 2025, 17(19), 3174; https://doi.org/10.3390/cancers17193174

6. “Dermal Mitoses Correlate with Surgical Burden in Lentigo Maligna Melanoma: PRAME for Margin Assessment”
by Thomas Leibing, Clara Ziemann, Cyrill Géraud, Jochen Utikal and Sebastian A. Wohlfeil
Cancers 2025, 17(19), 3112; https://doi.org/10.3390/cancers17193112

7. “The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy”
by Paige O. Mirsky, Patrick L. Wagner, Maja Mandic-Popov, Vera S. Donnenberg and Albert D. Donnenberg
Cancers 2025, 17(19), 3217; https://doi.org/10.3390/cancers17193217
